Posts

Something to chew on: Researchers look for connections in how animals eat and digest food

Something to chew on: Researchers look for connections ...

Oct 26, 2023

Oct. 26, 2023 Credit: Brooke Coupal/UMass Lowell Oct. 26, 2023 Media contacts: E...

SynGAP Research Fund awards $100,000 for investigating the impact of SYNGAP1 missense variants using structural bioinformatics

SynGAP Research Fund awards $100,000 for investigating ...

Oct 26, 2023

TURKU, Finland – October 27, 2023 – The SynGAP Research Fund 501(c)(3) announced...

Cutting-edge imaging sheds new light on cells that break down bone

Cutting-edge imaging sheds new light on cells that brea...

Oct 26, 2023

Bone may seem as if it’s a hard, lifeless structure, but now the cells living wi...

Controlling waves in magnets with superconductors for the first time

Controlling waves in magnets with superconductors for t...

Oct 26, 2023

Quantum physicists at Delft University of Technology have shown that it’s possib...

Common chemotherapy drugs don’t work like doctors thought, with big implications for drug discovery

Common chemotherapy drugs don’t work like doctors thoug...

Oct 26, 2023

A new study from the University of Wisconsin–Madison suggests that chemotherapy ...

A new NIR-PIT biomarker paves the way for targeted cancer treatments

A new NIR-PIT biomarker paves the way for targeted canc...

Oct 26, 2023

Researchers at Nagoya University in Japan and their collaborators have used a bi...

Merck eliminates two preclinical Kelun programs to reduce its ADC pipeline

Merck eliminates two preclinical Kelun programs to redu...

Oct 25, 2023

Merck & Co. has chosen to streamline its portfolio of antibody-drug conjugates (...

Roivant to Sell Gut Disease Drug to Roche in Deal Over $7B

Roivant to Sell Gut Disease Drug to Roche in Deal Over $7B

Oct 25, 2023

Approximately a year ago, pharmaceutical company Roivant Sciences established a ...

Roche invests $7 billion to compete with Merck in the bowel disease market

Roche invests $7 billion to compete with Merck in the b...

Oct 25, 2023

Roche has made a significant $7 billion investment to challenge Merck & Co in th...

Abemaciclib by Eli Lilly and Co for Neuroblastoma: Like...

Oct 25, 2023

Abemaciclib is under clinical development by Eli Lilly and Co and currently in P...

IMM-47 by ImmuneOnco Biopharmaceuticals (Shanghai) for ...

Oct 25, 2023

IMM-47 is under clinical development by ImmuneOnco Biopharmaceuticals (Shanghai)...

Alimta by Eli Lilly and Co for Triple-Negative Breast C...

Oct 25, 2023

Alimta is under clinical development by Eli Lilly and Co and currently in Phase ...

Trametinib dimethyl sulfoxide by Novartis for Relapsed ...

Oct 25, 2023

Trametinib dimethyl sulfoxide is under clinical development by Novartis and curr...

IMM-47 by ImmuneOnco Biopharmaceuticals (Shanghai) for ...

Oct 25, 2023

IMM-47 is under clinical development by ImmuneOnco Biopharmaceuticals (Shanghai)...

IMM-47 by ImmuneOnco Biopharmaceuticals (Shanghai) for ...

Oct 25, 2023

IMM-47 is under clinical development by ImmuneOnco Biopharmaceuticals (Shanghai)...

IMM-47 by ImmuneOnco Biopharmaceuticals (Shanghai) for ...

Oct 25, 2023

IMM-47 is under clinical development by ImmuneOnco Biopharmaceuticals (Shanghai)...